Investlytic Investlytic
Log in Free Account
English
🕒 Last update: loading…09/11/2026

Stock Viatris Inc. VTRS

Viatris Inc. — Investlytic score 1/5 on the five criteria.

-
-
20/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 1/5 criteria met. Data as of 03/10/2026.

  • ❌ Price trend failed
  • ⚠️ Mixed growth
  • ❌ Debt failed
  • ✅ P/E passed
  • ❌ Correction failed

Price trend

Overall trend (8 years): insufficient progression (less than x1.5).

Price change 2018 → 2019: -26.64%

Price change 2019 → 2020: -6.77%

Price change 2020 → 2021: -27.80%

Price change 2021 → 2022: -17.74%

Price change 2022 → 2023: -2.70%

Price change 2023 → 2024: 14.96%

Price change 2024 → 2025: 0.00%

Price change 2025 → 2026: 40.24%

Price change 2026 (year to date): 40.13%

Financial growth

Revenue CAGR (8 years): 3.25%

Earnings CAGR (8 years): N/A

Growth status: positive trend (>1%/yr) in revenue, earnings data insufficient/N/A.

Debt

Debt-to-equity ratio: 1.00

Debt/equity > 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: 6.98

P/E < 25.0 (maximum threshold).

Correction (6 months)

Current correction: 4.43% from the high over 6 months.

Insufficient correction (< 10.0%).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, model verdict (buy, watch, sell) and details of the 5 criteria · visible with a free account.

Create a free account Log in
02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
Viatris Inc.7.11.00+6.6 %🔒
Sartorius Stedim Biotech S.A.47.50.64+13.7 %–
bioMérieux S.A.22.50.11+7.6 %–
Moderna, Inc.–0.22+37.8 %–
EssilorLuxottica S.A.33.60.37+14.2 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

Create a free account Log in
04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

Create a free account Log in
05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

Create a free account Log in
06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

Create a free account Log in
+

Key reported figures

Revenue, net income and net margin reported by Viatris Inc. over the latest fiscal years.

Revenue
14.3 bn USD
fiscal year 2025
Net income
-3.5 bn USD
fiscal year 2025
Net margin
-24.6 %
fiscal year 2025
Average annual growth
+3.7 %
Revenue growth over 5 years
Average annual growth
+4.3 %
Revenue growth over 10 years
Market cap
22.9 bn USD
Fiscal yearRevenueNet incomeNet marginRevenue growth
202011.9 bn-670 m-5.6 %n/a
202117.9 bn-1.3 bn-7.1 %+49.7 %
202216.3 bn2.1 bn12.8 %-9.1 %
202315.4 bn54.7 m0.3 %-5.1 %
202414.7 bn-634 m-4.3 %-4.5 %
202514.3 bn-3.5 bn-24.6 %-3.0 %

Amounts converted to USD. Source: published annual accounts, collected on 06/11/2026.

+

Accounts and financial health

Balance sheet and cash flow published by Viatris Inc. over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).

Overview
fragile accounts
according to Altman Z, Piotroski and net debt
Altman Z-score
1.15
risk zone (below 1.81)
Piotroski Score
7 / 9
7 to 9: solid accounts
DCF Value
20.07 USD
DCF close to share price · share price 19.70 USD, gap +1.8 %
Net Debt / EBITDA
4.13 x
high debt
Fiscal year20212022202320242025
Cash and investments935 m1.5 bn1.2 bn1.1 bn1.5 bn
Total Debt23.4 bn19.5 bn18.4 bn14.3 bn14.7 bn
Net Debt22.7 bn18.3 bn17.4 bn13.6 bn13.4 bn
Equity20.5 bn21.1 bn20.5 bn18.6 bn14.7 bn
Total assets54.8 bn50.0 bn47.7 bn41.5 bn37.2 bn
Operating cash flow3.0 bn3.0 bn2.8 bn2.3 bn2.3 bn
Investments (capex)509 m489 m377 m326 m379 m
Free cash-flow2.5 bn2.5 bn2.3 bn2.0 bn1.9 bn
Share buybacks17.4 m0250 m250 m500 m
Dividends paid399 m582 m576 m575 m561 m

Amounts in USD, currency of the published accounts.

Trailing 12-month ratios

Price / earnings (P/E)-37.57 x
Price / book value1.67 x
Return on Equity (ROE)-4.2 %
Return on Invested Capital (ROIC)-0.3 %
Net margin-4.1 %
Debt / equity0.99 x
Current ratio1.55 x
Interest coverage-0.16 x
Free cash-flow yield8.9 %

Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 09/11/2026.

+

Valuation and competitors

Viatris Inc. compared with its sector on the same exchange and with its main competitors.

Company P/E
7.9
61.5 % below the sector
Sector median P/E
20.5
healthcare, Nasdaq
Sector over 10 years
26.5
10-year median, range 16.9 to 46.3

Direct competitors

CompanyMarket cap (USD)P/ENet margin
Viatris Inc.21.9 bn7.5-24.6 %
Teva Pharmaceutical Industries Limited TEVA49.0 bn14.48.2 %
Dr. Reddy's Laboratories Limited RDY11.8 bn30.117.4 %
Amneal Pharmaceuticals, Inc. AMRX6.9 bn23.92.4 %
ANI Pharmaceuticals, Inc. ANIP1.7 bn8.88.9 %
Bausch Health Companies Inc. BHC3.1 bn2.11.5 %
Organon & Co. OGN3.6 bn4.13.0 %
Haleon plc HLN38.1 bn17.715.1 %
Alkermes plc ALKS7.6 bn47.716.4 %
Sector median (Nasdaq)20.5

Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on . Competitors: comparable companies named by the data provider.

+

Analyst consensus and forecasts

What the financial analysts covering Viatris Inc. publish: ratings, price targets and earnings forecasts.

Majority rating
hold
13 analysts
Average price target
21.00 USD
from 14.00 USD to 26.00 USD, 11 targets over 12 months
Gap with the share price
+10.3 %
price 19.04 USD on 30/10/2026

Breakdown of ratings

strong buy 0buy 5hold 7sell 1strong sell 0

Analysts' average target 21.00 USD, DCF value 20.07 USD, share price 19.04 USD.

Average target over the last 3 months: 21.00 USD (5 targets).

Analyst forecasts

Fiscal yearRevenueNet incomeExpected EPS (range)P/E on this EPSAnalysts
202614.8 bn2.9 bn2.51 (2.46 / 2.55)7.67
202715.2 bn3.2 bn2.71 (2.59 / 2.81)7.07
202815.8 bn3.3 bn2.91 (1.87 / 4.08)6.53

Amounts in USD, the reporting currency.

Track record against expectations: reported EPS above consensus 9 times over the last 12 releases.

Rating changes (12 months)

DateFirmBeforeAfter
26/10/2026Piper SandlerNeutralNeutral
21/10/2026JP MorganNeutralNeutral
05/10/2026UBSBuyBuy
16/09/2026Piper SandlerNeutralNeutral
08/09/2026Argus ResearchBuyBuy

Source: ratings and forecasts published by analysts, collected on 07/11/2026. An analyst rating or target is not a guarantee.

+

Dividends and earnings

Viatris Inc.: dividend history, last distributions, stock splits and earnings releases.

Frequency
quarterly
Last dividend
0.120 USD
ex-dividend on 21/08/2026
Last 12 months
0.480 USD
number of payments: 4
Yield
3.9 %
on the last known price
Years of increases
0
consecutive
Years of payments
5
uninterrupted
00.120.240.360.482007 : 0.120 USD2008 : 0.0000 USD20082009 : 0.0000 USD2010 : 0.0000 USD20102011 : 0.0000 USD2012 : 0.0000 USD20122013 : 0.0000 USD2014 : 0.0000 USD20142015 : 0.0000 USD2016 : 0.0000 USD20162017 : 0.0000 USD2018 : 0.0000 USD20182019 : 0.0000 USD2020 : 0.0000 USD20202021 : 0.330 USD2022 : 0.480 USD20222023 : 0.480 USD2024 : 0.480 USD20242025 : 0.480 USD2026 : 0.360 USD2026

Annual dividend per share (USD), adjusted for splits. Light bar: current year, incomplete. Red bar: lower than the previous year.

Latest ex-dividend dates

Ex-dividendAmountPayment
21/08/20260.120 USD16/09/2026
22/05/20260.120 USD17/06/2026
09/03/20260.120 USD18/03/2026
24/11/20250.120 USD15/12/2025
22/08/20250.120 USD15/09/2025
23/05/20250.120 USD16/06/2025
10/03/20250.120 USD18/03/2025
22/11/20240.120 USD13/12/2024

Earnings releases

DatePublished EPSExpected EPSSurprise
06/08/20260.690.60+14.8 %
07/05/20260.590.50+17.5 %
26/02/20260.570.53+7.1 %
06/11/20250.670.62+7.9 %
07/08/20250.620.56+11.5 %
08/05/20250.500.49+1.6 %

Stock splits

DateOperation
09/10/2003split: 3 shares for 2
28/01/2003split: 3 shares for 2
16/08/1995split: 3 shares for 2
03/08/1992split: 2 shares for 1
04/08/1986split: 3 shares for 2
19/02/1985split: 2 shares for 1

Factual data: ex-dividend history and earnings calendar, as of 05/11/2026. A past dividend does not guarantee the next one.

+

Who owns the stock

Free float, institutional investors, large funds, executives and elected officials: declared positions in Viatris Inc.

Free float
99.4 %
share of freely traded shares
Large funds tracked
27
hold the stock as of 2026Q2
US elected officials
1
1 purchases, 0 sales in 12 months

Indices: S&P 500 (since 23/04/2004).

Large funds tracked

FundSharesValue (USD)Weight in the fundChangeQuarter
Vanguard Group138 m1.7 bn0.0 %-1.5 %2025Q4
State Street106 m1.7 bn0.0 %+103.2 %2026Q2
Fidelity96.7 m1.5 bn0.1 %+482.7 %2026Q2
BlackRock86.0 m1.4 bn0.0 %+2.0 %2026Q2
Davis Selected Advisers75.2 m1.2 bn5.1 %-3.8 %2026Q2
T. Rowe Price68.2 m1.1 bn0.1 %+3.6 %2026Q2
Geode Capital Management32.8 m520 m0.0 %+3.0 %2026Q2
Invesco20.8 m330 m0.0 %-5.5 %2026Q2

Elected officials' disclosures

DateOfficialSideAmount
18/11/2025Gilbert Cisnerospurchase$1,001 - $15,000

Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 08/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.

+

PEA and practical information

PEA eligibility
no
head office outside the EU and EEA
Listing exchange
Nasdaq
IPO: 17/03/1980
ISIN code
US92556V1061
Workforce
32,000
full-time employees
Chief executive
Scott Andrew Smith

Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.

?

Frequently asked questions about Viatris Inc.

What is the Viatris Inc. share price?

Latest recorded price: 19.91 USD on 06/11/2026, for a market cap of 22.9 bn USD.

What is the revenue of Viatris Inc.?

14.3 bn USD for fiscal year 2025, with net income of -3.5 bn USD (net margin -24.6 %).

Does Viatris Inc. pay a dividend?

Yes. Latest dividend: 0.120 USD per share, ex-dividend on 21/08/2026. Over 12 months: 0.480 USD. Yield on the latest known price: 3.9 %.

What do analysts say about Viatris Inc.?

Out of 13 analysts: 5 buy or strong buy, 7 hold, 1 sell or strong sell. Average price target: 21.00 USD, i.e. +10.3 % from the share price.

What is the P/E ratio of Viatris Inc.?

Trailing 12-month P/E of 7.9, against 20.5 for the sector median on the same exchange (10-year median: 26.5).

Is Viatris Inc. stock eligible for the French PEA?

No: the company is headquartered outside the European Union and the European Economic Area (ISIN US92556V1061).

How many employees does Viatris Inc. have?

32,000 full-time employees according to the latest published profile.

Who runs Viatris Inc.?

Scott Andrew Smith is the company's chief executive.

Which large funds own Viatris Inc.?

As of 2026Q2, among the large funds tracked: Vanguard Group, State Street, Fidelity, BlackRock, Davis Selected Advisers.

07

Similar stocks